Poziotinib shows activity and durability of responses in subgroups of previously treated EGFR exon 20 NSCLC patients.

被引：5

作者：

Le, Xiuning

Goldman, Jonathan Wade

Clarke, Jeffrey Melson

Tchekmedyian, Nishan

Piotrowska, Zofia

Chu, David

Bhat, Gajanan

Lebel, Francois M.

Socinski, Mark A.

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA

[2] Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA

[3] Duke Canc Inst, Durham, NC USA

[4] Pacific Shores Med Grp, Long Beach, CA USA

[5] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[6] North Shore Hematol Oncol Associates, East Setauket, NY USA

[7] Spectrum Pharmaceut, Irvine, CA USA

[8] AdventHlth Canc Inst, Orlando, FL USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9514

引用

页数：2